Prospects for immunotherapy and vaccines against Cryptosporidium
about
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeCryptosporidium in humans and animals-a one health approach to prophylaxis.Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.Prevalence of Cryptosporidium Infection among Inhabitants of 2 Rural Areas in White Nile State, SudanRevisiting the global problem of cryptosporidiosis and recommendationsProtective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice.Immune response of newborn BALB/c mice to Cryptosporidium infectionCryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitateA unique hexokinase in Cryptosporidium parvum, an apicomplexan pathogen lacking the Krebs cycle and oxidative phosphorylation.The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominisAddressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality.Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs.
P2860
Q27004488-94CAD4CE-EAFB-4BBF-AFDE-5F480DD89ED2Q30248799-3D785E79-2F58-498A-B3C2-B0F0D72C4B4AQ35951126-D1D2E04C-92EC-46D0-A0B6-506E1F9662A5Q36497404-3094FC35-16D5-4458-8403-517205DA266EQ37724846-F4E16C04-F64A-40DC-8824-6B63260D31DCQ40178686-F92FD8B7-5474-4B93-BF55-FAB9650E76A8Q40547869-E5684C81-3086-423D-A73E-CDCB119F1D93Q41323286-E628EA95-6A70-4FCA-BF90-3022AEEC42CEQ41741437-8585D0C1-FED8-4278-A866-6E00FD268BA5Q41991627-C56C512B-85F6-47B2-869D-F3161EBBD715Q43063649-27AAB8A4-1DE9-4D2A-8C56-73B3A3D21E4FQ47733620-101FB3C9-AABD-483C-96B1-3FE2521C32BBQ48260015-C662B2F9-A350-4CDD-BA0D-D39F01838B53Q50136314-67D628C2-6724-483B-A258-B19EA23878F7
P2860
Prospects for immunotherapy and vaccines against Cryptosporidium
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prospects for immunotherapy and vaccines against Cryptosporidium
@ast
Prospects for immunotherapy and vaccines against Cryptosporidium
@en
Prospects for immunotherapy and vaccines against Cryptosporidium
@nl
type
label
Prospects for immunotherapy and vaccines against Cryptosporidium
@ast
Prospects for immunotherapy and vaccines against Cryptosporidium
@en
Prospects for immunotherapy and vaccines against Cryptosporidium
@nl
prefLabel
Prospects for immunotherapy and vaccines against Cryptosporidium
@ast
Prospects for immunotherapy and vaccines against Cryptosporidium
@en
Prospects for immunotherapy and vaccines against Cryptosporidium
@nl
P2860
P921
P356
P1476
Prospects for immunotherapy and vaccines against Cryptosporidium
@en
P2093
Jan R Mead
P2860
P304
P356
10.4161/HV.28485
P407
P5008
P577
2014-01-01T00:00:00Z
2014-03-17T00:00:00Z